News
ENLV
0.8728
-8.32%
-0.0792
Weekly Report: what happened at ENLV last week (0330-0403)?
Weekly Report · 8h ago
Weekly Report: what happened at ENLV last week (0323-0327)?
Weekly Report · 03/30 10:21
Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets
TipRanks · 03/26 13:02
Enlivex Posts $1.23 Billion Profit for 2025 on Treasury Asset Gains
TipRanks · 03/25 12:59
Envilex Therapeutics GAAP EPS of $25.48
Seeking Alpha · 03/25 12:39
Crypto Currents: NYSE tokenization tests SEC and CFTC’s new crypto line
TipRanks · 03/24 15:55
Enlivex Secures $21 Million Convertible Debt, Expands RAIN Token Holdings and Launches $20 Million Buyback
TipRanks · 03/24 12:57
Enlivex Wins FDA IND Clearance for Global Phase 2b Trial of Allocetra in Knee Osteoarthritis
TipRanks · 03/23 12:26
Enlivex Therapeutics announces FDA clearance of Allocetra new drug application
TipRanks · 03/23 12:21
Enlivex Receives First FDA Approval For Phase2b Trial Of Allocetra For Age-Related Osteoarthritis
Benzinga · 03/23 12:09
Weekly Report: what happened at ENLV last week (0316-0320)?
Weekly Report · 03/23 10:17
Weekly Report: what happened at ENLV last week (0309-0313)?
Weekly Report · 03/16 10:17
Weekly Report: what happened at ENLV last week (0302-0306)?
Weekly Report · 03/09 10:17
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 03/02 21:06
Weekly Report: what happened at ENLV last week (0223-0227)?
Weekly Report · 03/02 10:16
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval
TipRanks · 02/23 13:50
Weekly Report: what happened at ENLV last week (0216-0220)?
Weekly Report · 02/23 10:16
Enlivex Therapeutics management to meet virtually with BTIG
TipRanks · 02/18 17:40
Weekly Report: what happened at ENLV last week (0209-0213)?
Weekly Report · 02/16 10:16
Enlivex’s RAIN Treasury Token Debuts on Kraken to Boost Liquidity
TipRanks · 02/10 13:49
More
Webull provides a variety of real-time ENLV stock news. You can receive the latest news about Enlivex Ltd through multiple platforms. This information may help you make smarter investment decisions.
About ENLV
Enlivex Ltd, formerly known as Enlivex Therapeutics Ltd, is an Israel-based clinical-stage macrophage reprogramming immunotherapy company developing Allocetra, an off-the-shelf cell therapy designed to restore macrophages to their homeostatic state. The Company focuses on diseases in which macrophages are pathologically reprogrammed, such as solid cancers, sepsis and COVID‑19, where non-homeostatic macrophages contribute significantly to disease severity. By re-establishing macrophage homeostasis, Allocetra has the potential to provide an immunotherapeutic mechanism of action for life-threatening indications defined as unmet medical needs, either as a stand‑alone therapy or in combination with other treatments.